BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17284963)

  • 1. CD4+ CD56+ hematodermic neoplasm.
    Cibull TL; Thomas AB; O'Malley DP; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):59-61. PubMed ID: 17284963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
    Campbell SM; Moad JC; Sammons DL; Zirwas M
    Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin manifestations in CD4+, CD56+ malignancies.
    Penven K; Macro M; Salaun V; Comoz F; Reman O; Leroy D; Troussard X; Petrella T; Dompmartin A
    Eur J Dermatol; 2003; 13(2):161-5. PubMed ID: 12695132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
    Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Images for diagnosis. CD4+CD56+ hematodermic neoplasm in a child.
    Guo X; Li Q; Zhou CY
    Chin Med J (Engl); 2010 Feb; 123(3):379-81. PubMed ID: 20193266
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous CD4+/CD56+ hematodermic neoplasm.
    Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+)/CD56(+) hematodermic neoplasm.
    Carlesimo M; Mari E; Cortesi G; Orsini D; Narcisi A; Cox MC; Ruco L; Pulcini F; Camplone G
    Eur J Dermatol; 2011; 21(2):291-2. PubMed ID: 21382786
    [No Abstract]   [Full Text] [Related]  

  • 11. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
    Weaver J; Hsi ED
    J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
    Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
    Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
    Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4/CD56 hematodermic neoplasm: a report of three cases.
    Ji H; Wang L; Li D; Zhang W; Wan C; Xu C; Li G
    Int J Dermatol; 2009 Jul; 48(7):743-8. PubMed ID: 19570082
    [No Abstract]   [Full Text] [Related]  

  • 17. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous tumors as the initial presentation of non-T, non-B, nonmyeloid CD4+ CD56+ hematolymphoid malignancy in an adolescent boy.
    Fass J; Tichy EH; Kraus EW; Herrick JL; Ehsan A; Peterson J; Grimwood RE
    Pediatr Dermatol; 2005; 22(1):19-22. PubMed ID: 15660891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic tumors in a 64-year-old man--quiz case. CD4(+)/CD56(+) hematodermic neoplasm.
    Valins W; Marchione R; Aber C; Amini S; Montague N; Milikowski C; Berman B
    Arch Dermatol; 2010 Oct; 146(10):1167-72. PubMed ID: 20956657
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.